Regulation of V2 vasopressin receptor degradation by agonist-promoted ubiquitination

被引:96
作者
Martin, NP
Lefkowitz, RJ [1 ]
Shenoy, SK
机构
[1] Duke Univ, Med Ctr, Dept Med, Howard Hughes Med Inst, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA
关键词
D O I
10.1074/jbc.M308285200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The seven-transmembrane-spanning vasopressin V2 receptor (V2R) is a G(s)-coupled receptor that is rapidly phosphorylated and internalized following stimulation with the agonist, arginine-vasopressin. Herein, we show that the V2R is ubiquitinated following agonist stimulation. V2R-ubiquitination is not observed in a beta-arrestin1,2 deleted mouse fibroblast cell line and is restored following introduction of beta-arrestin2, thus indicating that beta-arrestin2 is required for the ubiquitination of V2R. A mutant V2R (K268R) that is not ubiquitinated still activates G(s) and internalizes with similar kinetics as the wild type receptor. Unstimulated wild type and K268R mutant receptors degrade at similar rates and have comparable half-lives of 217 +/- 17 and 245 +/- 29 min as determined by pulse-chase experiments. However, following agonist stimulation, the rate of receptor degradation for the wild type is enhanced (half-life of 69 +/- 19 min), whereas that of the mutant is only minimally affected (half-life of 188 +/- 11 min). These data suggest that V2R levels are regulated through at least two processes. In the absence of agonist stimulation, a slow degradative pathway operates that is independent of receptor ubiquitination. However, receptor stimulation leads to rapid beta-arrestin2-dependent ubiquitination of the receptor and increased degradation.
引用
收藏
页码:45954 / 45959
页数:6
相关论文
共 23 条
[1]   V2R structure and diabetes insipidus [J].
Birnbaumer, M .
RECEPTORS & CHANNELS, 2002, 8 (01) :51-56
[2]   Cbl-mediated ubiquitinylation is required for lysosomal sorting of epidermal growth factor receptor but is dispensable for endocytosis [J].
Duan, L ;
Miura, Y ;
Dimri, M ;
Majumder, B ;
Dodge, IL ;
Reddi, AL ;
Ghosh, A ;
Fernandes, N ;
Zhou, PC ;
Mullane-Robinson, K ;
Rao, N ;
Donoghue, S ;
Rogers, RA ;
Bowtell, D ;
Naramura, M ;
Gu, H ;
Band, V ;
Band, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (31) :28950-28960
[3]   The ubiquitin-proteasome proteolytic pathway: Destruction for the sake of construction [J].
Glickman, MH ;
Ciechanover, A .
PHYSIOLOGICAL REVIEWS, 2002, 82 (02) :373-428
[4]   Components of a ubiquitin ligase complex specify polyubiquitination and intracellular trafficking of the general amino acid permease [J].
Helliwell, SB ;
Losko, S ;
Kaiser, CA .
JOURNAL OF CELL BIOLOGY, 2001, 153 (04) :649-662
[5]   Protein regulation by monoubiquitin [J].
Hicke, L .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2001, 2 (03) :195-201
[6]   Collecting and harvesting biological data: the GPCRDB and NucleaRDB information systems [J].
Horn, F ;
Vriend, G ;
Cohen, FE .
NUCLEIC ACIDS RESEARCH, 2001, 29 (01) :346-349
[7]   Phosphorylation and recycling kinetics of G protein-coupled receptors [J].
Innamorati, G ;
Sadeghi, H ;
Birnbaumer, M .
JOURNAL OF RECEPTOR AND SIGNAL TRANSDUCTION RESEARCH, 1999, 19 (1-4) :315-326
[8]   β-arrestin 1 and 2 differentially regulate heptahelical receptor signaling and trafficking [J].
Kohout, TA ;
Lin, FT ;
Perry, SJ ;
Conner, DA ;
Lefkowitz, RJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (04) :1601-1606
[9]   Structural requirements for V2 vasopressin receptor proteolytic cleavage [J].
Kojro, E ;
Postina, R ;
Gilbert, S ;
Bender, F ;
Krause, G ;
Fahrenholz, F .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1999, 266 (02) :538-548
[10]   INTERNALIZATION OF VASOPRESSIN ANALOGS IN KIDNEY AND SMOOTH-MUSCLE CELLS - EVIDENCE FOR RECEPTOR-MEDIATED ENDOCYTOSIS IN CELLS WITH V2 OR V1 RECEPTORS [J].
LUTZ, W ;
SANDERS, M ;
SALISBURY, J ;
KUMAR, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (17) :6507-6511